Chongqing Pharscin Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 354.65 million compared to CNY 362.52 million a year ago. Revenue was CNY 360.46 million compared to CNY 367.63 million a year ago.

Net income was CNY 41.36 million compared to CNY 51.97 million a year ago. Basic earnings per share from continuing operations was CNY 0.099 compared to CNY 0.1296 a year ago. Diluted earnings per share from continuing operations was CNY 0.099 compared to CNY 0.1296 a year ago.